Turnstone Biologics Statistics

Total Valuation

TSBX has a market cap or net worth of $8.33 million. The enterprise value is -$13.00 million.

Market Cap	8.33M
Enterprise Value	-13.00M

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025, after market close.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

TSBX has 23.14 million shares outstanding. The number of shares has increased by 38.81% in one year.

Current Share Class	23.14M
Shares Outstanding	23.14M
Shares Change (YoY)	+38.81%
Shares Change (QoQ)	+0.34%
Owned by Insiders (%)	3.83%
Owned by Institutions (%)	26.38%
Float	14.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.39
P/TBV Ratio	0.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.70, with a Debt / Equity ratio of 0.03.

Current Ratio	3.70
Quick Ratio	3.01
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -126.03% and return on invested capital (ROIC) is -74.70%.

Return on Equity (ROE)	-126.03%
Return on Assets (ROA)	-63.31%
Return on Invested Capital (ROIC)	-74.70%
Return on Capital Employed (ROCE)	-303.57%
Revenue Per Employee	n/a
Profits Per Employee	-$4.50M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, TSBX has paid $23,000 in taxes.

Income Tax	23,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -86.06% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-86.06%
50-Day Moving Average	0.35
200-Day Moving Average	0.45
Relative Strength Index (RSI)	58.86
Average Volume (20 Days)	610,052

Short Selling Information

The latest short interest is 160,154, so 0.69% of the outstanding shares have been sold short.

Short Interest	160,154
Short Previous Month	306,394
Short % of Shares Out	0.69%
Short % of Float	1.14%
Short Ratio (days to cover)	1.81

Income Statement

Revenue	n/a
Gross Profit	-56.33M
Operating Income	-61.79M
Pretax Income	-75.09M
Net Income	-63.01M
EBITDA	-60.16M
EBIT	-61.79M
Earnings Per Share (EPS)	-$2.73

Full Income Statement

Balance Sheet

The company has $21.85 million in cash and $690,000 in debt, giving a net cash position of $21.16 million or $0.91 per share.

Cash & Cash Equivalents	21.85M
Total Debt	690,000
Net Cash	21.16M
Net Cash Per Share	$0.91
Equity (Book Value)	19.99M
Book Value Per Share	0.86
Working Capital	19.60M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$57.07 million and capital expenditures -$85,000, giving a free cash flow of -$57.15 million.

Operating Cash Flow	-57.07M
Capital Expenditures	-85,000
Free Cash Flow	-57.15M
FCF Per Share	-$2.47

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSBX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-38.81%
Shareholder Yield	-38.81%
Earnings Yield	-772.63%
FCF Yield	-700.78%

Analyst Forecast

The average price target for TSBX is $4.75, which is 1,219.44% higher than the current price. The consensus rating is "Buy".

Price Target	$4.75
Price Target Difference	1,219.44%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1